有源植入式式医疗设备的全球市场：依产品、最终用户、地区

预计2024年全球主动植入式医疗设备市场规模将达255.2亿美元，2024年至2031年复合年增长率为7.2%，2031年将达416.3亿美元。

图：2024 年按地区分類的植入式医疗设备市场占有率 (%)

全球人口老化和慢性病盛行率的增加推动了有源植入式医疗设备的全球市场成长。植入式式医疗设备是植入人体以治疗各种医疗状况的电池供电医疗设备。主要的植入式医疗设备包括植入式心臟去颤器（ICD）、神经刺激设备和植入式药物帮浦。 ICD 广泛用于治疗危及生命的心臟疾病，例如心搏过速和心室颤动。神经刺激设备有助于治疗慢性疼痛以及癫痫和帕金森氏症等神经系统疾病。植入式药物帮浦可支援癌症和关节炎等疾病的有效局部药物传递。持续的医疗进步以及对小型化和技术先进的植入式设备开发的日益关注可能会在预测期内推动植入式医疗设备市场的强劲增长。

市场动态：

易患慢性病的老年人口不断增加，对微创手术的需求不断增加，以及心臟疾病和神经系统疾病盛行率的增加，可能会推动有源植入式式医疗设备的全球市场成长。据联合国称，到 2050 年，全球 60 岁以上人口预计将从目前的 10 亿增加到 21 亿。由于长期疗效和易于远端监控等优点，与传统药物和医疗设备相比，植入式医疗设备越来越偏好，这推动了有源植入式医疗设备的采用。然而，高成本植入式医疗设备的报销范围有限，特别是在新兴国家，由于安全问题而频繁发生产品召回，以及严格的监管核准，这可能会阻碍预测期内的市场成长。机器人、生物列印和3D列印领域的持续技术创新，以及用于长期植入的小型电池供电设备的开拓，可以为积极进取的植入式医疗设备市场参与者提供成长机会。

本研究的主要特点

本报告对全球主动植入式医疗设备市场进行了详细分析，包括年复合成长率（CAGR%） 。

它还揭示了各个细分市场的潜在商机，并说明了该市场有吸引力的投资提案矩阵。

它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要见解。

它根据公司亮点、产品系列、主要亮点、财务表现和策略等参数，介绍了全球有源植入式医疗设备市场的主要企业。

主要企业包括美敦力 (Medtronic)、科利耳有限公司 (Cochlear Ltd)、雅培 (Abbott)、LivaNova PLC、波士顿科学公司 (Boston Scientific Corporation)、Myomo, Inc. 等。

该报告的见解使负责人和公司经营团队能够就未来的产品发布、升级、市场扩张和行销策略做出明智的决策。

全球有源植入式式医疗设备市场报告迎合了该行业的各种相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。

透过用于分析全球植入式医疗设备市场的各种策略矩阵，将有助于相关人员做出决策。

目录

第一章 研究目的与前提

• 研究目的
• 先决条件
• 简称

第二章 市场展望

• 报告说明
  • 市场定义和范围
• 执行摘要

第三章 市场动态、法规与趋势分析

• 市场动态
  • 促进因素
  • 抑制因素
  • 机会
• 影响分析
• 市场趋势
• 主要进展
• 监管场景
• 收购和合作场景
• 资金筹措和投资
• PEST分析
• 波特的分析

第 4 章全球主动植入式医疗设备市场 – COVID-19 的影响

• 整体影响
• 政府倡议
• COVID-19 对市场的影响

第五章全球有源植入式医疗设备市场（按产品），2019-2031（十亿美元）

• 植入式心臟去颤器
• 植入式心臟心律调节器
• 辅助人工心臟
• 植入式心臟监测仪/植入式循环记录仪
• 神经刺激设备
• 植入式助听器及其他

第六章 全球主动植入式医疗设备市场，依最终用户划分，2019-2031 年（十亿美元）

• 医院
• 门诊手术中心
• 专科诊所
• 其他的

第七章2019-2031年全球主动植入式医疗设备市场（按地区）（十亿美元）

• 拉丁美洲
• 欧洲
• 亚太地区
• 中东

第八章 竞争格局

• 公司简介
  • Medtronic plc
  • Abbott Laboratories
  • Boston Scientific Corporation
  • LivaNova PLC
  • Biotronik SE &Co. KG
  • Cochlear Ltd.
  • William Demant Holding A/S
  • Sonova Holding AG
  • MED-EL
  • Nurotron Biotechnology Co. Ltd.
  • Zimmer Biomet Holdings, Inc.
  • Nevro Corp.
  • Second Sight Medical Products, Inc.
  • Nuvectra Corporation
  • Aleva Neurotherapeutics SA
  • Pixium Vision
  • Retina Implant AG
  • Corindus Vascular Robotics, Inc.

第九章 分析师建议

• 命运之轮
• 分析师观点
• 一致的机会图

第10章调查方法

• 参考
• 调查方法

Global active implantable medical devices market is estimated to be valued at USD 25.52 Bn in 2024 and is expected to reach USD 41.63 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 7.2% from 2024 to 2031.

Figure. Active Implantable Medical Devices Market Share (%), By Region 2024

Global active implantable medical devices market growth is driven by rising aging population and increasing prevalence of chronic diseases worldwide. Active implantable medical devices are battery-powered medical devices that are implanted inside the human body to treat various medical conditions. Some key active implantable medical devices include implantable cardioverter defibrillators (ICDs), neurostimulators, and implantable drug pumps. ICDs are extensively used to treat life-threatening cardiac conditions like tachycardia and ventricular fibrillation. Neurostimulators help in managing chronic pain as well as neurological disorders such as epilepsy and Parkinson's disease. Implantable drug pumps assist in effective localized drug delivery for conditions like cancer and arthritis. Ongoing medical advancement and growing focus on development of miniaturized and technologically advanced implantable devices can drive the active implantable medical devices market growth during the forecast period.

Market Dynamics:

Rising geriatric population base that is highly susceptible to chronic diseases, increasing demand for minimally invasive procedures, growing prevalence of cardiac disorders and neurological conditions can drive the global active implantable medical devices market growth. According to the United Nations, the population aged 60 years and above is projected to reach 2.1 billion globally by 2050 from 1 billion currently. Growing preference for implantable devices over conventional drug therapy and medical devices due to advantages such as long-term effectiveness and easy remote monitoring can boost adoption of active implantable medical devices. However, limited reimbursement coverage for high-cost implantable devices especially in developing nations, frequent product recalls owing to safety issues, and stringent regulatory approvals can hamper the market growth during the forecast period. Ongoing technological innovation in the field of robotics, bioprinting, 3D printing and development of miniature battery powered devices for long term implantation can offer growth opportunities for active implantable medical devices market players.

Key features of the study:

This report provides in-depth analysis of the global active implantable medical devices market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global active implantable medical devices market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Medtronic, Cochlear Ltd, Abbott, LivaNova PLC, Boston Scientific Corporation, Myomo, Inc.

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

Global active implantable medical devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global active implantable medical devices market

Detailed Segmentation-

• By Product
  • Implantable Cardioverter Defibrillators
  • Implantable Cardiac Pacemakers
  • Ventricular Assist Devices
  • Implantable Heart Monitors/Insertable Loop Recorders
  • Neurostimulators
  • Implantable Hearing Devices
  • Others
• By End Users
  • Hospitals
  • Ambulatory Surgery Center
  • Specialty Clinics
  • Others
• By Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • Medtronic plc
  • Abbott Laboratories
  • Boston Scientific Corporation
  • LivaNova PLC
  • Biotronik SE & Co. KG
  • Cochlear Ltd.
  • William Demant Holding A/S
  • Sonova Holding AG
  • MED-EL
  • Nurotron Biotechnology Co. Ltd.
  • Zimmer Biomet Holdings, Inc.
  • Nevro Corp.
  • Second Sight Medical Products, Inc.
  • Nuvectra Corporation
  • Aleva Neurotherapeutics SA
  • Pixium Vision
  • Retina Implant AG
  • Corindus Vascular Robotics, Inc.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Product
  • Market Snapshot, By End User
  • Market Snapshot, By Region

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Regulatory Scenario
• Acquisitions and Partnerships Scenario
• Funding and Investments
• PEST Analysis
• Porter's Analysis

4. Global Active Implantable Medical Devices Market- Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the Market

5. Global Active Implantable Medical Devices Market, By Product, 2019 - 2031, (USD Bn)

• Overview
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Implantable Cardioverter Defibrillators
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Implantable Cardiac Pacemakers
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Ventricular Assist Devices
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Implantable Heart Monitors/Insertable Loop Recorders
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Neurostimulators
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Implantable Hearing Devices
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Others (fully-automatic vial-filling machine, etc.)
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Active Implantable Medical Devices Market, By End User, 2019 - 2031, (USD Bn)

• Overview
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Hospitals
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Ambulatory Surgery Center
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Specialty Clinics
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Active Implantable Medical Devices Market, By Region, 2019 - 2031, (USD Bn)

• Introduction
  • Market Share Analysis, By Region, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, For Region, 2020-2031
  • Regional Trends
    • North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
    • North Africa
    • Central Africa
    • South Africa

8. Competitive Landscape

• Company Profiles
  • Medtronic plc
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Abbott Laboratories
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Boston Scientific Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • LivaNova PLC
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Biotronik SE & Co. KG
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Cochlear Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • William Demant Holding A/S
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Sonova Holding AG
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • MED-EL
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Nurotron Biotechnology Co. Ltd.
  • Zimmer Biomet Holdings, Inc.
  • Nevro Corp.
  • Second Sight Medical Products, Inc.
  • Nuvectra Corporation
  • Aleva Neurotherapeutics SA
  • Pixium Vision
  • Retina Implant AG
  • Corindus Vascular Robotics, Inc.

9. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

10. Research Methodology

• References
• Research Methodology
• About us and Sales Contact